These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11466679)

  • 21. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
    Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
    Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.
    Geismann C; Morscheck M; Koch D; Bergmann F; Ungefroren H; Arlt A; Tsao MS; Bachem MG; Altevogt P; Sipos B; Fölsch UR; Schäfer H; Müerköster SS
    Cancer Res; 2009 May; 69(10):4517-26. PubMed ID: 19435915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity.
    Inoue H; Tsuchida A; Kawasaki Y; Fujimoto Y; Yamasaki S; Kajiyama G
    Cancer; 2001 Jan; 91(1):35-41. PubMed ID: 11148557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
    Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
    Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis.
    Rückert F; Samm N; Lehner AK; Saeger HD; Grützmann R; Pilarsky C
    BMC Cancer; 2010 Jul; 10():379. PubMed ID: 20646298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
    Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
    Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
    Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic Pancreatitis Finding by Endoscopic Ultrasonography in the Pancreatic Parenchyma of Intraductal Papillary Mucinous Neoplasms Is Associated with Invasive Intraductal Papillary Mucinous Carcinoma.
    Takenaka M; Masuda A; Shiomi H; Yagi Y; Zen Y; Sakai A; Kobayashi T; Arisaka Y; Okabe Y; Kutsumi H; Toyama H; Fukumoto T; Ku Y; Kudo M; Azuma T
    Oncology; 2017; 93 Suppl 1():61-68. PubMed ID: 29258092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S100P is a novel marker to identify intraductal papillary mucinous neoplasms.
    Nakata K; Nagai E; Ohuchida K; Hayashi A; Miyasaka Y; Aishima S; Oda Y; Mizumoto K; Tanaka M; Tsuneyoshi M
    Hum Pathol; 2010 Jun; 41(6):824-31. PubMed ID: 20153506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis.
    Kawasaki H; Toyoda M; Shinohara H; Okuda J; Watanabe I; Yamamoto T; Tanaka K; Tenjo T; Tanigawa N
    Cancer; 2001 Jun; 91(11):2026-32. PubMed ID: 11391581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intraductal papillary mucinous neoplasm of pancreas: a clinicopathologic and immunohistochemical study of 19 cases].
    Huo Z; Yang D; Chang XY; Wan JW; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2008 Oct; 37(10):670-5. PubMed ID: 19094485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dermokine expression in intraductal papillary-mucinous neoplasm and invasive pancreatic carcinoma.
    Watanabe K; Oochiai T; Kikuchi S; Kumano T; Matsui T; Morimoto K; Yasukawa S; Nakamori S; Sasako M; Yanagisawa A; Otsuji E
    Anticancer Res; 2012 Oct; 32(10):4405-12. PubMed ID: 23060565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraductal papillary-mucinous tumors of the pancreas.
    Kubosawa H; Uehara T; Watanabe Y; Urashima T; Matsubara H; Asano T; Ochiai T
    Hepatogastroenterology; 2004; 51(59):1489-94. PubMed ID: 15362784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pdcd4 expression in intraductal papillary mucinous neoplasm of the pancreas: its association with tumor progression and proliferation.
    Hayashi A; Aishima S; Miyasaka Y; Nakata K; Morimatsu K; Oda Y; Nagai E; Oda Y; Tanaka M; Tsuneyoshi M
    Hum Pathol; 2010 Nov; 41(11):1507-15. PubMed ID: 20656320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery?
    Jang JY; Kim SW; Ahn YJ; Yoon YS; Choi MG; Lee KU; Han JK; Kim WH; Lee YJ; Kim SC; Han DJ; Kim YI; Choi SH; Cho BH; Yu HC; Yoon DS; Lee WJ; Lee KB; Kim YC; Lee KS; Kim MW; Kim HJ; Kim HJ; Park YH
    Ann Surg Oncol; 2005 Feb; 12(2):124-32. PubMed ID: 15827792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of pancreatitis-associated protein (PAP) in human pancreatic ductal adenocarcinoma.
    Xie MJ; Motoo Y; Iovanna JL; Su SB; Ohtsubo K; Matsubara F; Sawabu N
    Dig Dis Sci; 2003 Mar; 48(3):459-64. PubMed ID: 12757156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas.
    Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
    JAMA Surg; 2017 Mar; 152(3):e165054. PubMed ID: 28122068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma.
    Sarela AI; Verbeke CS; Ramsdale J; Davies CL; Markham AF; Guillou PJ
    Br J Cancer; 2002 Mar; 86(6):886-92. PubMed ID: 11953819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.